Английская Википедия:Deuruxolitinib
Материал из Онлайн справочника
Шаблон:Short description Шаблон:Infobox drug
Deuruxolitinib (CTP-543) is a Janus kinase inhibitor selective for JAK1 and JAK2. It is in development to treat alopecia areata.[1] If approved the drug would compete with others with a similar mechanism of action developed by Eli Lilly and Pfizer.[2]
Deuruxolitinib is a deuterated derivative of ruxolitinib.
References